Home »
2024 Issues »
89 FR (09/20/2024) » 2024-21575. Chemical Analysis for Biocompatibility Assessment of Medical Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
2024-21575. Chemical Analysis for Biocompatibility Assessment of Medical Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
21 CFR part; guidance; or FDA form |
Topic |
OMB control No. |
807, subpart E |
Premarket notification |
0910-0120 |
814, subparts A through E |
Premarket approval |
0910-0231 |
814, subpart H |
Humanitarian Device Exemption |
0910-0332 |
812 |
Investigational Device Exemption |
0910-0078 |
860, subpart D |
De Novo classification process |
0910-0844 |
“Requests for Feedback on Medical Device Submissions: The Q-Submission Program and Meetings with Food and Drug Administration Staff” |
Q-Submissions and Early Payor Feedback Request Programs for Medical Devices |
0910-0756 |
Document Information
- Published:
- 09/20/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice of availability.
- Document Number:
- 2024-21575
- Dates:
- Submit either electronic or written comments on the draft guidance by November 19, 2024 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance.
- Pages:
- 77162-77164 (3 pages)
- Docket Numbers:
- Docket No. FDA-2024-D-4165
- PDF File:
-
2024-21575.pdf